COPD Exacerbation Syndrome: The Spanish Perspective on an Old Dilemma

References

• Ancochea J, Soriano JB. COPD in Spain at the start of a new decade. Arch Bronconeumol. 2021;57(1):1–2. doi:10.1016/j.arbres.2020.01.025
   Web of Science ®Google Scholar
• López-Campos JL, Carrasco-Hernández L, Román Rodríguez L, Quintana-Gallego E, Carmona Bernal C, Alcázar Navarrete B. Implicaciones clínicas del uso de la triple terapia en combinación de dosis fija en EPOC: del ensayo al paciente. Archivos de Bronconeumología. 2020;56(4):242–248. doi:10.1016/j.arbres.2019.11.011
   PubMed Web of Science ®Google Scholar
• Gea J. COPD therapy: beyond conventional pharmacology. Arch Bronconeumol. 2020;56(6):343–344. doi:10.1016/j.arbres.2019.06.023
   PubMed Web of Science ®Google Scholar
• Tekerlek H, Cakmak A, Calik-Kutukcu E, et al. Exercise capacity and activities of daily living are related in patients with chronic obstructive pulmonary disease. Arch Bronconeumol. 2020;56(4):208–213. doi:10.1016/j.arbres.2019.06.015
   PubMed Web of Science ®Google Scholar
• Garrido Ocana AI, Gonzalez Fernandez-Palacios M, Matute de Cárdenas JA, et al. Successful lobectomy in preterm with diffuse persistent interstitial pulmonary emphysema. Arch Bronconeumol. 2020;56(7):461–463. doi:10.1016/j.arbres.2019.10.029
   PubMed Web of Science ®Google Scholar
• Lujan M, Ergan B. Guidelines for chronic non-invasive ventilation in COPD: from experience to evidence. Arch Bronconeumol. 2021;57(3):158–159. doi:10.1016/j.arbres.2020.03.016
   PubMed Web of Science ®Google Scholar
• Galdiz JB, Gomez A, Rodriguez D, et al. Telerehabilitation programme as a maintenance strategy for COPD patients: a 12-month randomized clinical trial. Arch Bronconeumol. 2021;57(3):195–204.
   PubMed Web of Science ®Google Scholar
• Diaz Lopez JM, Giran Gonzalez B, Alcazar-Navarrete B. Personalized medicine in chronic obstructive pulmonary disease: how close are we? Arch Bronconeumol. 2020;56(7):420–421. doi:10.1016/j.arbr.2019.09.013
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Soler-Cataluna JJ, Miravitlles M. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2019 report: future challenges. Arch Bronconeumol. 2020;56(2):65–67. doi:10.1016/j.arbres.2019.06.001
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Calle M, Molina J, et al. Spanish COPD guidelines (GesEPOC) 2021: updated pharmacological treatment of stable COPD. Arch Bronconeumol. 2022;58(1):69–81. doi:10.1016/j.arbres.2021.03.005
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Pinera P, Trigueros JA, et al. Spanish COPD guidelines (GesEPOC) 2021 update diagnosis and treatment of COPD exacerbation syndrome. Arch Bronconeumol. 2022;58(2):159–170. doi:10.1016/j.arbres.2021.05.033
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Almagro P, Gomez JT, et al. Spanish COPD guideline (GesEPOC) update: comorbidities, self-management and palliative care. Arch Bronconeumol. 2022;58(4):334–344. doi:10.1016/j.arbres.2021.08.002
   PubMed Web of Science ®Google Scholar
• Cosio BG, Hernandez C, Chiner E, et al. Spanish COPD guidelines (GesEPOC 2021): non-pharmacological treatment update. Arch Bronconeumol. 2022;58(4):345–351. doi:10.1016/j.arbres.2021.08.024
   PubMed Web of Science ®Google Scholar
• Cosio BG, Shafiek H, Verdu J, et al. Implementation of an integrated care model for frequent-exacerbator COPD patients: a controlled prospective study. Arch Bronconeumol. 2021;57(9):577–583. doi:10.1016/j.arbres.2021.01.025
   PubMed Web of Science ®Google Scholar
• Meeraus WH, DeBarmore BM, Mullerova H, Fahy WA, Benson VS. Terms and definitions used to describe recurrence, treatment failure and recovery of acute exacerbations of COPD: a systematic review of observational studies. Int J Chron Obstruct Pulmon Dis. 2021;16:3487–3502. doi:10.2147/COPD.S335742
   PubMed Web of Science ®Google Scholar
• Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J. 2018;52(5):1801261. doi:10.1183/13993003.01261-2018
   PubMed Web of Science ®Google Scholar
• Duarte-de-Araújo A, Fonte P, Teixeira P, Hespanhol V, Correia-de-Sousa J. Is an early diagnosis of COPD clinically useful? Archivos de Bronconeumología. 2020;56(6):409–410. doi:10.1016/j.arbres.2019.11.018
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2022.
   Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152(5 Pt 2):S77–S121.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5Suppl 2):398s–401s. doi:10.1378/chest.117.5_suppl_2.398S
   PubMed Web of Science ®Google Scholar
• Celli BR, Agusti A. COPD: time to improve its taxonomy? ERJ Open Res. 2018;4(1):00132–2017. doi:10.1183/23120541.00132-2017
   PubMedGoogle Scholar
• Chang CL, Robinson SC, Mills GD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax. 2011;66(9):764–768. doi:10.1136/thx.2010.155333
   PubMed Web of Science ®Google Scholar
• Nishimura K, Nishimura T, Onishi K, Oga T, Hasegawa Y, Jones PW. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:155–162. doi:10.2147/COPD.S55143
   PubMed Web of Science ®Google Scholar
• Han W, Wang M, Xie Y, Ruan H, Zhao H, Li J. Prevalence of pulmonary embolism and deep venous thromboembolism in patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:732855. doi:10.3389/fcvm.2022.732855
   PubMed Web of Science ®Google Scholar
• Park HJ, Kim SH, Kim HC, et al. Utility of computed tomography in a differential diagnosis for the patients with an initial diagnosis of chronic obstructive pulmonary disease exacerbation. Tuberc Respir Dis. 2019;82(3):234–241. doi:10.4046/trd.2018.0087
   PubMed Web of Science ®Google Scholar
• Parker CM, Voduc N, Aaron SD, Webb KA, O’Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26(3):420–428. doi:10.1183/09031936.05.00136304
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC
   PubMed Web of Science ®Google Scholar
• Gao P, Zhang J, He X, Hao Y, Wang K, Gibson PG. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS One. 2013;8(5):e57678. doi:10.1371/journal.pone.0057678
   PubMed Web of Science ®Google Scholar
• Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008;177(4):396–401. doi:10.1164/rccm.200708-1290OC
   PubMed Web of Science ®Google Scholar
• Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383(1):35–48. doi:10.1056/NEJMoa1916046
   PubMed Web of Science ®Google Scholar
• Lipson DA, Barnhart F, Brealey N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378(18):1671–1680. doi:10.1056/NEJMoa1713901
   PubMed Web of Science ®Google Scholar
• Leidy NK, Wilcox TK, Jones PW, et al. Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med. 2011;183(3):323–329. doi:10.1164/rccm.201005-0762OC
   PubMed Web of Science ®Google Scholar
• Aaron SD, Donaldson GC, Whitmore GA, Hurst JR, Ramsay T, Wedzicha JA. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67(3):238–243. doi:10.1136/thoraxjnl-2011-200768
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Rodriguez-Roisin R. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious? COPD. 2010;7(4):276–284. doi:10.3109/15412555.2010.496817
   PubMedGoogle Scholar
• Hurst JR, Donaldson GC, Quint JK, Goldring JJ, Baghai-Ravary R, Wedzicha JA. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(5):369–374. doi:10.1164/rccm.200807-1067OC
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Jacobs DM, Noyes K, Zhao J, et al. Early hospital readmissions after an acute exacerbation of chronic obstructive pulmonary disease in the nationwide readmissions database. Ann Am Thorac Soc. 2018;15(7):837–845. doi:10.1513/AnnalsATS.201712-913OC
   PubMed Web of Science ®Google Scholar
• Alqahtani JS, Mandal S, Hurst JR. The impact of re-admissions in COPD. Arch Bronconeumol. 2022;58(2):109–110. doi:10.1016/j.arbres.2021.06.006
   PubMed Web of Science ®Google Scholar
• Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016;47(1):113–121. doi:10.1183/13993003.01391-2014
   PubMed Web of Science ®Google Scholar
• Celli BR, Fabbri LM, Aaron SD, et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal. Am J Respir Crit Care Med. 2021;204(11):1251–1258. doi:10.1164/rccm.202108-1819PP
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Sliwinski P, Rhee CK, et al. Changes in control status of COPD over time and their consequences: a prospective international study. Arch Bronconeumol. 2021;57(2):122–129. doi:10.1016/j.arbres.2020.06.003
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi:10.1164/ajrccm.161.5.9908022
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Miralles C. Exacerbation Syndrome in COPD: a Paradigm Shift. Arch Bronconeumol. 2021;57(4):246–248. doi:10.1016/j.arbr.2020.07.021
   PubMed Web of Science ®Google Scholar
• Saleh A, Lopez-Campos JL, Hartl S, Pozo-Rodriguez F, Roberts CM. The effect of incidental consolidation on management and outcomes in COPD exacerbations: data from the European COPD audit. PLoS One. 2015;10(7):e0134004. doi:10.1371/journal.pone.0134004
   PubMed Web of Science ®Google Scholar
• Williams NP, Ostridge K, Devaster JM, et al. Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD. Respir Res. 2018;19(1):143. doi:10.1186/s12931-018-0842-8
   PubMed Web of Science ®Google Scholar
• Monso E. Look at the wood and not at the tree: the microbiome in chronic obstructive lung disease and cystic fibrosis. Arch Bronconeumol. 2020;56(1):5–6. doi:10.1016/j.arbr.2019.04.014
   PubMed Web of Science ®Google Scholar
• Huerta A, Crisafulli E, Menendez R, et al. Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics. Chest. 2013;144(4):1134–1142. doi:10.1378/chest.13-0488
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol. 2017;53(6):324–335. doi:10.1016/j.arbres.2017.03.018
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Agusti A. Heterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposal. Lancet Respir Med. 2015;3(9):729–734. doi:10.1016/S2213-2600(15)00242-8
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015
   PubMed Web of Science ®Google Scholar
• Singh D, Bafadhel M, Brightling CE, et al. Blood eosinophil counts in clinical trials for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020;202(5):660–671. doi:10.1164/rccm.201912-2384PP
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Monteagudo M, Solntseva I, Alcazar B. Blood eosinophil counts and their variability and risk of exacerbations in COPD: a population-based study. Arch Bronconeumol. 2021;57(1):13–20. doi:10.1016/j.arbres.2019.12.015
   PubMed Web of Science ®Google Scholar
• Schumann DM, Tamm M, Kostikas K, Stolz D. Stability of the blood eosinophilic phenotype in stable and exacerbated cOPD. Chest. 2019;156(3):456–465. doi:10.1016/j.chest.2019.04.012
   PubMed Web of Science ®Google Scholar
• Marcos PJ, Lopez-Campos JL. Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of chronic obstructive pulmonary disease (COPD)? CON. Med Sci. 2018;6:2.
   Google Scholar
• Asensio VJ, Tomas A, Iglesias A, et al. Eosinophilic COPD patients display a distinctive serum miRNA profile from asthma and non-eosinophilic COPD. Arch Bronconeumol. 2020;56(4):234–241. doi:10.1016/j.arbres.2019.09.020
   PubMed Web of Science ®Google Scholar
• Golpe R, Dacal D, Sanjuan-Lopez P, Martin-Robles I, Perez-de-Llano LA. Plasma eosinophil count and patient-centered events in chronic obstructive pulmonary disease in real-life clinical practice. Arch Bronconeumol. 2020;56(2):129–130. doi:10.1016/j.arbres.2019.09.015
   PubMed Web of Science ®Google Scholar
• Hegewald MJ, Horne BD, Trudo F, et al. Blood eosinophil count and hospital readmission in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2629–2641. doi:10.2147/COPD.S251115
   PubMed Web of Science ®Google Scholar
• Kang HS, Kim SK, Kim YH, et al. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. BMC Pulm Med. 2021;21(1):74. doi:10.1186/s12890-021-01443-4
   PubMed Web of Science ®Google Scholar
• Garcia Sanz MT, Gonzalez Barcala FJ. Establishing the prognosis of COPD exacerbations using risk scales from the point of view of the emergency department. Arch Bronconeumol. 2020;56(2):63–64. doi:10.1016/j.arbr.2019.04.017
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. doi:10.1136/thoraxjnl-2012-202103
   PubMed Web of Science ®Google Scholar
• Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–1602. doi:10.1001/archinternmed.2009.270
   PubMedGoogle Scholar
• Quintana JM, Esteban C, Unzurrunzaga A, et al. Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments. BMC Med. 2014;12:66. doi:10.1186/1741-7015-12-66
   PubMed Web of Science ®Google Scholar
• Roche N, Chavaillon JM, Maurer C, Zureik M, Piquet J. A clinical in-hospital prognostic score for acute exacerbations of COPD. Respir Res. 2014;15:99. doi:10.1186/s12931-014-0099-9
   PubMed Web of Science ®Google Scholar
• Eccles SR, Subbe C, Hancock D, Thomson N. CREWS: improving specificity whilst maintaining sensitivity of the National Early Warning Score in patients with chronic hypoxaemia. Resuscitation. 2014;85(1):109–111. doi:10.1016/j.resuscitation.2013.08.277
   PubMed Web of Science ®Google Scholar
• Echevarria C, Steer J, Bourke SC. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score. Thorax. 2019;74(10):941–946. doi:10.1136/thoraxjnl-2019-213470
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-201518
   PubMed Web of Science ®Google Scholar
• García-Quero C, García-Río F. Smoking-induced small airway dysfunction. an early marker of future COPD? Arch Bronconeumol. 2021;57(1):3–4. doi:10.1016/j.arbres.2020.02.006
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Novella L, Soler C, et al. Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap. Arch Bronconeumol. 2020;56(5):282–290. doi:10.1016/j.arbr.2020.03.003
   PubMed Web of Science ®Google Scholar
• Fernandez-Garcia S, Represas-Represas C, Ruano-Ravina A, Botana-Rial M, Martinez-Reglero C, Fernandez Villar A. Dependence in performing activities as a predictor of mortality following hospitalization for chronic obstructive pulmonary disease exacerbation. Arch Bronconeumol. 2020;56(5):291–297. doi:10.1016/j.arbr.2020.03.004
   PubMed Web of Science ®Google Scholar
• Erro Iribarren M, Alonso Perez T, Soriano JB, Ancochea Bermudez J. Adjusting the level of intervention in patients with chronic obstructive pulmonary disease according to the risk stratification proposed by the Spanish COPD guidelines (GesEPOC) version 2017. Arch Bronconeumol. 2020;56(3):183–185. doi:10.1016/j.arbres.2019.09.016
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Alcázar B, Miravitlles M. Clinical control in COPD: a new therapeutic objective? Arch Bronconeumol. 2020;56(2):68–69. doi:10.1016/j.arbres.2019.06.004
   PubMed Web of Science ®Google Scholar
• Marcos PJ, Represas Represas C, Ramos C, et al. Impact of a home telehealth program after a hospitalized COPD exacerbation: a propensity score analysis. Arch Bronconeumol. 2022;58(6):474–481. doi:10.1016/j.arbres.2020.05.030
   PubMedGoogle Scholar
• Montes de Oca M, Lopez Varela MV, Acuna A, et al. Incorporating new evidence on inhaled medications in COPD. The Latin American Chest Association (ALAT) 2019. Arch Bronconeumol. 2020;56(2):106–113. doi:10.1016/j.arbres.2019.09.023
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2022. Available from: https://goldcopd.org/. Accessed December 20, 2022.
   Google Scholar